The percentages of IL-21-producing PD-1+ CD4+ T-cells were not significantly different in SLE patients as compared to healthy controls (12.6 ± 11.0% vs. 14.7 ± 16.2%; p = 0.91, Fig. 2). The gene discussed is IL21; the disease is systemic lupus erythematosus.